Awakn Life Sciences Corp. reported earnings results for the first quarter ended April 30, 2024. For the first quarter, the company reported revenue was CAD 0.020679 million compared to CAD 0.011993 million a year ago.

Net loss was CAD 0.544815 million compared to CAD 1.59 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.